Home/Filings/4/0001415889-24-015148
4//SEC Filing

Heath-Chiozzi Margo 4

Accession 0001415889-24-015148

CIK 0000744218other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:06 PM ET

Size

16.8 KB

Accession

0001415889-24-015148

Insider Transaction Report

Form 4
Period: 2024-05-30
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
Transactions
  • Sale

    Common Stock

    2024-05-30$34.07/sh38,719$1,319,1567,094 total
  • Exercise/Conversion

    Common Stock

    2024-05-30$2.78/sh+29,068$80,80941,162 total
  • Exercise/Conversion

    Common Stock

    2024-05-30$9.02/sh+2,043$18,42143,205 total
  • Exercise/Conversion

    Common Stock

    2024-05-30$10.38/sh+2,608$27,07145,813 total
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2024-05-3029,06812,732 total
    Exercise: $2.78Exp: 2029-06-19Common Stock (29,068 underlying)
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2024-05-302,0436,289 total
    Exercise: $9.02Exp: 2028-06-13Common Stock (2,043 underlying)
  • Exercise/Conversion

    Incentive Stock Option (Right to Buy)

    2024-05-302,60881,392 total
    Exercise: $10.38Exp: 2030-06-18Common Stock (2,608 underlying)
Footnotes (5)
  • [F1]Includes 847 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  • [F3]As of June 19, 2023, the option is fully vested.
  • [F4]As of June 13, 2022, the option is fully vested.
  • [F5]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Issuer

Celldex Therapeutics, Inc.

CIK 0000744218

Entity typeother

Related Parties

1
  • filerCIK 0001718112

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:06 PM ET
Size
16.8 KB